Form 4 for ZLAB Zai Lab Ltd
Accepted 2021-07-19 00:00:00 ET · period of report 2021-07-15 · accession 0001567619-21-013659 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-19 | 2021-07-15 | ZLAB | Fu Tao | Pres, COO, Dir | S - Sale+OE | $172.82 | -10.0K | 207.1K | -5% | -$1.73M |
| D | 2021-07-19 | 2021-07-15 | ZLAB | Fu Tao | Pres, COO, Dir | M - OptEx | $18.92 | +10.0K | 217.0K | +5% | +$189.2K |
| D | 2021-07-19 | 2021-07-15 | ZLAB | Fu Tao | Pres, COO, Dir | M - OptEx | $0.00 | -10.0K | 440.0K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-07-15 | S | D | 21 | $171.89 | 213,646 | D | — | — | |
| 2 | Common | Ordinary Shares | 2021-07-15 | S | D | 1,000 | $171.36 | 213,667 | D | — | — | (F3) Reflects a weighted average sale price of $171.36 per share, at prices ranging from $170.89 to $171.88 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Ordinary Shares | 2021-07-15 | M | A | 10,000 | $18.92 | 217,000 | D | — | — | |
| 4 | Common | Ordinary Shares | 2021-07-15 | S | D | 3,281 | $173.56 | 210,365 | D | — | — | (F4) Reflects a weighted average sale price of $173.56 per share, at prices ranging from $172.94 to $173.93 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Common | Ordinary Shares | 2021-07-15 | S | D | 2,333 | $170.30 | 214,667 | D | — | — | (F2) Reflects a weighted average sale price of $170.30 per share, at prices ranging from $169.81 to $170.64 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 6 | Common | Ordinary Shares | 2021-07-15 | S | D | 100 | $175.00 | 207,000 | D | — | — | (F2) Reflects a weighted average sale price of $170.30 per share, at prices ranging from $169.81 to $170.64 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 7 | Common | Ordinary Shares | 2021-07-15 | S | D | 3,265 | $174.26 | 207,100 | D | — | — | (F5) Reflects a weighted average sale price of $174.26 per share, at prices ranging from $173.94 to $174.80 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 8 | Derivative | Stock Options (Right to Buy) | 2021-07-15 | M | D | 10,000 | $0.00 | 440,000 | D | $18.92 · — to 2028-07-24 | 10,000 Ordinary Shares | (F7) The Stock Options vest in equal annual installments over five years beginning on 09/24/2019, the first anniversary of the date of grant. |